STEPHY.T.P, SREEJITH. K, and Dr. BINDU G. “Comparison of Quality of Life (QOL) for Patients With Breast Cancer Receiving Adjuvant Tac (docetaxel, Doxorubicin, Cyclophosphamide) and Fac (5-Fluorouracil, Doxorubicin, Cyclophosphamide) Therapy”. International Journal of Pharma and Bio Sciences 8, no. 3 (September 30, 2017): 373–382. Accessed September 3, 2026. https://ijpbs.net/index.php/journal/article/view/6006.